Akers Bio

Home » Akers Bio

Secondary

Akers Bio

Akers Bio develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a time- and cost-efficient manner.

Symbol

AKER

Final Price
$0.40

Shares
13,600,000

Effective Date
December 19, 2017

Underwriters
Joseph Gunnar & Co.

To view the prospectus for Akers Bio, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253